757
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Breast cancer incidence and mortality in the Nordic capitals, 1970–1998. Trends related to mammography screening programmes

, , , , , , , & show all
Pages 528-535 | Received 19 Aug 2005, Published online: 08 Jul 2009

References

  • Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1(8433)829–32
  • Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297: 943–8
  • Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist L-E, Somell A. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18: 49–56
  • Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, et al. The Gothenburg Breast Screening Trial. Cancer 2003; 97(10)2387–96
  • Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359(9310)909–19
  • Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 361(9367)1405–10
  • N Perry, Broeders, M, de Wolf, C, Törnberg, S, editors. European Guidelines for Quality Assurance in Mammography Screening. Third edition. Luxembourg: Europe Against Cancer, European Commission; 2001.
  • de Waard F, Kirkpatrick A, Perry NM, Tornberg S, Tubiana M, de Wolf C. Breast cancer screening in the framework of the Europe against Cancer programme. Eur J Cancer Prev 1994; 3 Suppl 1: 3–5
  • Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000; 36(12)1473–8
  • Council of the European Union. Council Recommendation of 2 Dec 2003 on cancer screening 2003/87/EC. Official J European Union 2003: 16.2.2003: L327/34–L327/38.
  • Törnberg S, Carstensen J, Hakulinen T, Lenner P, Hatschek T, Lundgren B. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. J Med Screen 1994; 1: 184–7
  • Hakama M, Pukkala E, Heikkila M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study [see comments]. BMJ 1997; 314(7084)864–7
  • Jonsson H, Nystrom L, Tornberg S, Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 2001; 8(3)152–60
  • Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002; 95(3)458–69
  • Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005; 330(7485)220
  • Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002; 9(4)153–8
  • Lidbrink EK, Tornberg SA, Azavedo EM, Frisell JO, Hjalmar ML, Leifland KS, et al. The general mammography screening program in Stockholm. Organisation and first-round results. Acta Oncol 1994; 33(4)353–8
  • Vejborg I, Olsen AH, Jensen MB, Rank F, Tange UB, Lynge E. Early outcome of mammography screening in Copenhagen 1991–99. J Med Screen 2002; 9(3)115–9
  • Jensen A, Olsen AH, von Euler-Chelpin M, Helle Njor S, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere?. Int J Cancer 2005; 113(3)464–70
  • Wang H, Karesen R, Hervik A, Thoresen SO. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control 2001; 12(1)39–45
  • Karesen, R, Jacobsen, U, Sauer, T, Skaane, P. [A prospective registration of diagnosis and treatment of breast tumors at the Ulleval hospital 1988-1995]. Tidsskr Nor Laegeforen 1999;119(24):3562–6, (in Norwegian).
  • Rostgaard K, Vaeth M, Holst H, Madsen M, Lynge E. Age-period-cohort modelling of breast cancer incidence in the Nordic countries. Stat Med 2001; 20(1)47–61
  • Blanks RG, Moss SM, Patnick J. Results from the UK NHS breast screening programme 1994–1999. J Med Screen 2000; 7(4)195–8
  • Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003; 361(9367)1411–7
  • Paci E, Giorgi D, Bianchi S, Vezzosi V, Zappa M, Crocetti E, et al. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 2002; 38(4)568–73
  • Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96. Br J Cancer 2002; 87(1)65–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.